# ImmunityBio, Inc.: Form 8-K, filed Mar 11, 2016

- Company: [ImmunityBio, Inc.](/companies/ibrx.md) (CIK 1326110)
- Form: 8-K
- Filed: 2016-03-11
- Accepted by EDGAR: Mar 11, 2016, 09:02 ET
- Period: 2016-03-10
- Accession: 0001193125-16-500957
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1326110/000119312516500957/d158471d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326110/000119312516500957/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326110/000119312516500957/d158471d8k.htm

Filed Mar 11, 2016.
Source: SEC EDGAR, the filing index for accession 0001193125-16-500957. Last ingested by Listed: Nov 9, 2026, 17:45 ET. No prices; not investment advice.
